GE Healthcare purchased Thermo Fisher’s research tools for $1 billion. Becton Dickinson acquires point-of-care diagnostic maker Alverix for $40 million. More news briefs.
GE Healthcare Technologies Inc. announced Jan. 6 that it is purchasing Thermo Fisher Scientific Inc.’s HyClone cell culture media and sera, and gene modulation and magnetic beads businesses for about $1.06 billion.
The HyClone line of products includes mixing stations for biomanufacturing, as well as a variety of cell culture media, serum and reagents. In addition, GE Healthcare said in a statement...
During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.
Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
